TABLE 1. Patients and disease characteristics.

Characteristics	Number of subjects N=25
Age median (range)	55 (34-78)
Gender (male/female)	13/12
Race
Caucasians	20
Hispanic	3
Black	2
Disease
Acute lymphoblastic leukemia	10
Chronic lymphocytic leukemia	5
Non-Hodgkin lymphoma	10
Disease status
Primary refractory	11
Relapsed refractory	14
Site of disease
Marrow	13
Extramedullary ALL	1
Lymph nodes	15
Extra lymphatic sites	3
CD19 and CD22 expression on tumor
CD19 only	11
CD22 only	1
CD19 and 22 both	13
Prior therapy
Lines median (range)	5 (1-5)
Rituximab	14
Ofatumumab	1
Inotuzumab	1
Autologous hematopoietic cell transplantation	3
Allogeneic hematopoietic cell transplantation	5